ETFsMSCI China ESG Selection P-Series Extra Net Total Return Index
Amundi

Amundi MSCI China ESG Selection Extra UCITS ETF Acc

ASI PAAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
96.06EUR
+0.42% · +€0.40
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
ASIBase
Fund charges
0.65%Total expense ratio (TER)
Fund size
€444.2Mall share classes
Return 1Y
-18.0%
Sharpe 3Y
0.23
Volatility 1Y
17.1%annualised
Holdings
163Fund holdings

Performance

Compare
  • ASI-18.0%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
ASI-4.0%-8.5%-6.5%-11.8%-18.0%+19.4%-21.7%
MSCI World+0.4%+4.9%+10.8%+16.3%+15.9%+75.5%+71.2%
Gap to MSCI World-4.4%-13.4%-17.3%-28.1%-33.9%-56.1%-92.9%

Risk and return

Sharpe ratio · 3Y
0.23
Below MSCI World · 1.24
Return p.a.
+5.8%
Volatility
24.7%
Max loss
-22.4%Jun 2026

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
ASI
0.23
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
62.3%
Holdings
163
As of
Fund holdings
  1. 1TENCENT HOLDINGS LTDKYG87572163414.32%
  2. 2ALIBABA GROUP HOLDING LTDKYG01719114213.12%
  3. 3CHINA CONSTRUCTION BANK HKCNE1000002H19.04%
  4. 4IND & COMM BK OF CHINA-HCNE1000003G15.37%
  5. 5XIAOMI CORPKYG9830T10674.66%
  6. 6BANK OF CHINA LTD-HCNE1000001Z54.35%
  7. 7MEITUAN-CLASS BKYG5966910413.70%
  8. 8NETEASE INCKYG6427A10223.22%
  9. 9JD.COM INC-CLASS AKYG8208B10142.40%
  10. 10CHINA MERCHANTS BANK HKGCNE1000002M12.12%

Countries

Classified 100.0%
Largest
100.0%China
Top 3
100.0%
Effective number
1.01 / HHI

Market cap

Weight vs holdings

62.3%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-163

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.